Alkermes gains; Cerus, InterMune tumble

Drug stocks dip in early action Tuesday, while shares of Alkermes gain on positive news about two of its substance-abuse therapies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.